Incannex Healthcare (IXHL) Liabilities and Shareholders Equity (2020 - 2026)

Incannex Healthcare's (IXHL) quarterly Liabilities and Shareholders Equity came in at $80.3 million in Q1 2026, up 395.67% year-on-year from $16.2 million in Q1 2025, and up 7.04% quarter-over-quarter from $75.0 million in Q4 2025.

Incannex Healthcare (IXHL) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Incannex Healthcare has disclosed Liabilities and Shareholders Equity across 7 years of filings, most recently posting $80.3 million for Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $80.3 million, up 395.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $254.5 million (up 321.3% YoY), and the FY2025 annual result was $20.4 million, up 19.94% from the prior year.
  • Liabilities and Shareholders Equity came in at $80.3 million for Q1 2026 at Incannex Healthcare, up from $75.0 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $80.3 million in Q1 2026 to a low of $11.1 million in Q4 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $21.4 million (2023), against an average of $34.7 million.
  • Across the five-year window, Liabilities and Shareholders Equity tumbled 50.33% in 2024 and jumped 575.36% in 2025, its largest moves.
  • Incannex Healthcare's Liabilities and Shareholders Equity stood at $37.9 million in 2022, then slumped by 40.97% to $22.4 million in 2023, then plunged by 50.33% to $11.1 million in 2024, then surged by 575.36% to $75.0 million in 2025, then grew by 7.04% to $80.3 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $80.3 million (Q1 2026), $75.0 million (Q4 2025), and $78.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 40.04 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 15.15 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 6.71 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 555.95 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 4.91 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.22 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 4.26 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 2.27 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.35 Bn
10 Incannex Healthcare 45.81 Mn 45.81 Mn - 80.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 80.28 Mn
Dec 31, 2025 75.01 Mn
Sep 30, 2025 78.72 Mn
Jun 30, 2025 20.45 Mn
Mar 31, 2025 16.20 Mn
Dec 31, 2024 11.11 Mn
Sep 30, 2024 16.05 Mn
Jun 30, 2024 17.05 Mn
Mar 31, 2024 17.25 Mn
Dec 31, 2023 22.36 Mn
Jun 30, 2023 23.78 Mn
Jun 30, 2022 37.88 Mn
Jun 30, 2021 9.33 Mn
Jun 30, 2020 4.24 Mn